Cancer Genetics (Biopharma Services) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Cancer Genetics (Biopharma Services) General Information

Description

Provider of biopharmaceutical services based in Rutherford, New Jersey. The company offers pharmacogenomics testing, genotyping, and biorepository services to the pharmaceutical and biotech industries.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Rutherford, NJ
  • United States
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • Rutherford, NJ
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cancer Genetics (Biopharma Services) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cancer Genetics (Biopharma Services)‘s full profile, request access.

Request a free trial

Cancer Genetics (Biopharma Services) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cancer Genetics (Biopharma Services)‘s full profile, request access.

Request a free trial

Cancer Genetics (Biopharma Services) FAQs

  • Where is Cancer Genetics (Biopharma Services) headquartered?

    Cancer Genetics (Biopharma Services) is headquartered in Rutherford, NJ.

  • What industry is Cancer Genetics (Biopharma Services) in?

    Cancer Genetics (Biopharma Services)’s primary industry is Laboratory Services (Healthcare).

  • Is Cancer Genetics (Biopharma Services) a private or public company?

    Cancer Genetics (Biopharma Services) is a Private company.

  • What is the current valuation of Cancer Genetics (Biopharma Services)?

    The current valuation of Cancer Genetics (Biopharma Services) is .

  • What is Cancer Genetics (Biopharma Services)’s current revenue?

    The current revenue for Cancer Genetics (Biopharma Services) is .

  • Who are Cancer Genetics (Biopharma Services)’s investors?

    Vyant Bio has invested in Cancer Genetics (Biopharma Services).

  • When was Cancer Genetics (Biopharma Services) acquired?

    Cancer Genetics (Biopharma Services) was acquired on 15-Jul-2019.

  • Who acquired Cancer Genetics (Biopharma Services)?

    Cancer Genetics (Biopharma Services) was acquired by Interpace Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process